132 related articles for article (PubMed ID: 2408723)
1. Ca2 and Ca3. New monoclonal antibodies evaluated as tumor markers in serous effusions.
Bramwell ME; Ghosh AK; Smith WD; Wiseman G; Spriggs AI; Harris H
Cancer; 1985 Jul; 56(1):105-10. PubMed ID: 2408723
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies.
Ghosh AK; Spriggs AI; Taylor-Papadimitriou J; Mason DY
J Clin Pathol; 1983 Oct; 36(10):1154-64. PubMed ID: 6194183
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies in the cytodiagnosis of serous effusions.
al-Nafussi A; Carder PJ
Cytopathology; 1990; 1(2):119-28. PubMed ID: 1714782
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.
Ghosh AK; Mason DY; Spriggs AI
J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182
[TBL] [Abstract][Full Text] [Related]
5. Immunocytological staining reactions of anti-carcinoembryonic antigen, Ca, and anti-human milk fat globule monoclonal antibodies on benign and malignant exfoliated mesothelial cells.
Ghosh AK; Butler EB
J Clin Pathol; 1987 Dec; 40(12):1424-7. PubMed ID: 3323250
[TBL] [Abstract][Full Text] [Related]
6. Reactivity of tumor cells in malignant effusions with a panel of monoclonal and polyclonal antibodies.
Shaw P; Buckman R; Law J; Baumal R; Marks A
Tumour Biol; 1988; 9(2-3):101-9. PubMed ID: 3041546
[TBL] [Abstract][Full Text] [Related]
7. Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen.
Mezger J; Stötzer O; Schilli G; Bauer S; Wilmanns W
Acta Cytol; 1992; 36(1):75-81. PubMed ID: 1546516
[TBL] [Abstract][Full Text] [Related]
8. Tumour associated antigens in diagnosis of serous effusions.
Mezger J; Permanetter W; Gerbes AL; Wilmanns W; Lamerz R
J Clin Pathol; 1988 Jun; 41(6):633-43. PubMed ID: 2454957
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions.
Lee JS; Nam JH; Lee MC; Park CS; Juhng SW
Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic interest of the monoclonal antibody CA1 in malignant pleural effusion.
Font P; Palacìn A; Font J; Faus R; Molina R; Ballesta AM; Cardesa A; Ingelmo M
Int J Biol Markers; 1987; 2(3):157-60. PubMed ID: 2453591
[TBL] [Abstract][Full Text] [Related]
11. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
[TBL] [Abstract][Full Text] [Related]
12. Oncofetal antigens as tumor markers in the cytologic diagnosis of effusions.
Orell SR; Dowling KD
Acta Cytol; 1983; 27(6):625-9. PubMed ID: 6196931
[TBL] [Abstract][Full Text] [Related]
13. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions.
Epenetos AA; Canti G; Taylor-Papadimitriou J; Curling M; Bodmer WF
Lancet; 1982 Nov; 2(8306):1004-6. PubMed ID: 6127499
[TBL] [Abstract][Full Text] [Related]
14. Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions.
To A; Coleman DV; Dearnaley DP; Ormerod MG; Steele K; Neville AM
J Clin Pathol; 1981 Dec; 34(12):1326-32. PubMed ID: 7035498
[TBL] [Abstract][Full Text] [Related]
15. Value of immunocytochemistry in the study of malignant effusions.
Mason MR; Bedrossian CW; Fahey CA
Diagn Cytopathol; 1987 Sep; 3(3):215-21. PubMed ID: 3311665
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum CA 125 levels in patients with benign ascitic or pleural effusions.
Mezger J; Wilmanns W; Lamerz R
Tumour Biol; 1988; 9(1):47-52. PubMed ID: 3163160
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions.
Singer S; Boddington MM; Hudson EA
J Clin Pathol; 1985 Feb; 38(2):180-4. PubMed ID: 3881482
[TBL] [Abstract][Full Text] [Related]
18. A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody.
Woods JC; Spriggs AI; Harris H; McGee JO
Lancet; 1982 Sep; 2(8297):512-4. PubMed ID: 6125677
[TBL] [Abstract][Full Text] [Related]
19. P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining.
Stoetzer OJ; Munker R; Darsow M; Wilmanns W
Oncol Rep; 1999; 6(2):455-8. PubMed ID: 10023021
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
